Literature DB >> 23593750

[Successful treatment with levetiracetam in a case of Ohtahara syndrome caused by STXBP1 mutation].

S Yamashita, T Chiyonobu, M Yoshida, M Moroto, T Morita, S Morioka, M Kato, H Saitsu, M Morimoto, H Hosoi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23593750

Source DB:  PubMed          Journal:  No To Hattatsu        ISSN： 0029-0831


× No keyword cloud information.
  2 in total

1.  Perampanel markedly improved clinical seizures in a patient with a Rett-like phenotype and 960-kb deletion on chromosome 9q34.11 including the STXBP1.

Authors:  Syun Yoshida; Masano Amamoto; Tomoyuki Takahashi; Ichiro Tomita; Kotaro Yuge; Munetsugu Hara; Kazuhiro Iwama; Naomichi Matsumoto; Toyojiro Matsuishi
Journal:  Clin Case Rep       Date:  2022-05-15

Review 2.  Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review.

Authors:  Shunli Liu; Liyuan Wang; Xiao Tang Cai; Hui Zhou; Dan Yu; Zhiling Wang
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.